Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046761 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
A Phase 2 study, sponsored by Ono Pharma USA.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,320
- Enrollment target
NCT00046761 is a Phase 2 study that was terminated before completion, run by Ono Pharma USA. The registered enrollment target is 1,320 participants.
The verdict
NCT00046761, a Phase 2 study, was terminated before completion, sponsored by Ono Pharma USA.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,320 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.
Interventions
- DRUG ONO-2506
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2002-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046761
The ClinicalTrials.gov registry entry for NCT00046761 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1,320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharma USA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONO-2506 is the first listed.
NCT00046761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046761 about?
NCT00046761 is a clinical study titled "A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke". The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.
What is the current status of trial NCT00046761?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,320 participants. The study started on 2002-11.
What interventions are being tested in trial NCT00046761?
The interventions under investigation include: ONO-2506 (DRUG).
Who is sponsoring clinical trial NCT00046761?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.